Atrás
Rango del Día
$10.32
$11.21
Rango de 52 Semanas
$5.90
$14.51
Volumen
868,056
Promedio 50D / 200D
$12.71
/
$10.01
Cierre Anterior
$10.94
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -8.2 | 0.4 |
| P/B | 1.5 | 2.9 |
| ROE % | -16.2 | 3.7 |
| Net Margin % | -30.8 | 3.8 |
| Rev Growth 5Y % | 48.8 | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Revenue grew 48.78% annually over 5 years — strong growth
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -275.70M
PEG of 0.18 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 49.08%
Capital efficient — spends only 0.72% of revenue on capex
Crecimiento
Revenue Growth (5Y)
48.78%
Revenue (1Y)-0.30%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-16.23%
ROIC-19.48%
Net Margin-30.77%
Op. Margin-43.75%
Seguridad
Debt / Equity
0.02
Current Ratio4.92
Interest Coverage0.00
Valoración
P/E Ratio
-8.20
P/B Ratio1.53
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.30% | Revenue Growth (3Y) | 82.90% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 48.78% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 262.60M | Net Income (TTM) | -80.80M |
| ROE | -16.23% | ROA | -11.26% |
| Gross Margin | 98.02% | Operating Margin | -43.75% |
| Net Margin | -30.77% | Free Cash Flow (TTM) | -275.70M |
| ROIC | -19.48% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 4.92 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -8.20 | P/B Ratio | 1.53 |
| P/S Ratio | 2.52 | PEG Ratio | 0.18 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 662.79M | Enterprise Value | 528.39M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 262.60M | 263.40M | 78.50M | 131.40M | 53.60M |
| Net Income | -80.80M | -198.90M | -367.30M | -282.50M | -191.00M |
| EPS (Diluted) | -1.28 | -2.77 | -6.62 | -5.31 | -3.82 |
| Gross Profit | 257.40M | 263.40M | 78.50M | 131.40M | 53.60M |
| Operating Income | -114.90M | -250.20M | -401.50M | -263.20M | -188.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 717.90M | 1.09B | 1.30B | 1.27B | 1.58B |
| Total Liabilities | 284.00M | 529.70M | 644.60M | 703.90M | 799.90M |
| Shareholders' Equity | 433.90M | 561.70M | 660.00M | 564.90M | 781.70M |
| Total Debt | 8.50M | 9.70M | 3.20M | 5.50M | 5.00M |
| Cash & Equivalents | 142.90M | 100.50M | 311.70M | 81.30M | 108.30M |
| Current Assets | 700.70M | 1.07B | 1.28B | 1.24B | 1.55B |
| Current Liabilities | 142.50M | 229.80M | 257.10M | 295.10M | 261.70M |